羅替戈汀為選擇性多巴胺D1/D2/D3受體激動(dòng)劑，其透皮貼劑是第一個(gè)非麥角類(lèi)多巴胺受體激動(dòng)劑貼劑。羅替戈汀貼劑24 h有效，能對(duì)帕金森病人持續(xù)提供多巴胺能刺激，目前獲得FDA和EMA批準(zhǔn)上市。對(duì)羅替戈汀貼劑研究情況進(jìn)行簡(jiǎn)要綜述。

Rotigotine transdermal patch is the first transdermal non-ergot dopamine agonist, which is a selective dopamine D1/D2/D3 receptor agonist. Rotigotine patch is effective over 24 h providing a continuous dopaminergic stimulation in patients with Parkinson’s disease (PD) and is approved for use in treatment of PD by the FDA and EMA. This paper is a review of current status of Rotigotine transdermal patch.